Forecasts
Financial Statements
AI Powered Summary
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Ask AI
Consolidated Half Yearly Results (in ₹ Crores)
View Standalone
View Standalone
Consolidated Profit Loss (in ₹ Crores)
View Standalone
View Standalone
Consolidated Balance Sheet (in ₹ Crores)
View Standalone
View Standalone
Consolidated Cash Flows (in ₹ Crores)
View Standalone
View Standalone
Projection
Documents
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI


Frequently Asked Questions about Unihealth Hospitals Ltd
Unihealth Hospitals Ltd (UNIHEALTH) is currently trading at 318.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
UniHealth Hospitals Limited is a healthcare service provider operating medical centers, hospitals, and consultancy services across India and Africa. It is engaged in medical value travel, enhancing patient access to advanced medical care. The company reported significant financial growth with revenues rising to ₹66.67 Cr in H1 FY26, and a notable improvement in EBITDA margin to 49.76%, reflecting enhanced operational efficiency. It has expanded its footprint by launching a new 52-bedded hospital in Navi Mumbai and plans to commission another 200-bedded facility in Nashik, signaling aggressive capacity expansion. The acquisition of Biohealth Limited in Tanzania marks a strategic step to strengthen UniHealth’s global presence, particularly in Africa, facilitating better control and growth in the region. Strategic initiatives include opening new clinics, scaling up IVF and fertility services in Uganda, and maintaining robust expansion plans with a target to reach 1,000 operational beds over the next two years.
Over the past 52 weeks, Unihealth Hospitals Ltd has traded between a low of ₹130.05 and a high of ₹390.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Unihealth Hospitals Ltd has a market capitalization of approximately 498.40. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Unihealth Hospitals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 32.38 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 498.40 Cr, Unihealth Hospitals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Unihealth Hospitals Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Unihealth Hospitals Ltd is 32.38. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
